— Get the $1 Sling Day Pass subscription now through November 30, 2025, as many times as you want. — The announcement follows Sling's recent legal victory in which a federal court denied Disney's request for a preliminary injunction, allowing Sling to continue offering its flexible, customer-first subscription model. Sling TV, the most flexible streaming […]
Conagra Brands, Inc. (NYSE: CAG) will release its fiscal 2026 second quarter results on Friday, December 19, 2025. A press release and supplemental materials, including pre-recorded remarks, will be issued that morning prior to a live question-and-answer session with the investment community at 9:30 a.m. ET. https://mma.prnewswire.com/media/479094/CB_CMYK_Texture_Logo.jpg The pre-recorded remarks, transcript, press release, presentation slides,
Backed by a Fortune 500 Global Leader in AI, Cloud and Data-Center Infrastructure AMPERA, a next-generation nuclear energy company, has officially emerged from stealth mode to unveil one of the most advancedsubcritical thorium breeder microreactor systemsever developed – purpose-built to power the AI era with compact, emission-free, autonomous energy. https://mma.prnewswire.com/media/2827010/AMPERA_Nuclear_Reactor.jpg Backed by aFortune 500 global
XPLR Infrastructure, LP (NYSE: XIFR) today announced the results of the previously announced cash tender offer (the “offer”) by its direct subsidiary, XPLR Infrastructure Operating Partners, LP (“XPLR OpCo”) (the “offeror”), for any and all of its outstanding 3.875% senior notes due 2026 (the “OpCo 2026 notes”). https://mma.prnewswire.com/media/2607570/XPLR_logo_TM_c_1_Logo.jpg As of 5:00 p.m., New York City
ABS is pioneering a personalized, genetically guided immuno-corrective therapy designed to normalize elevated levels of soluble IL7 receptor. Autoimmunity BioSolutions (ABS), is pioneering a personalized, genetically guided immuno-corrective therapy designed to normalize or “correct” elevated levels of soluble IL7 receptor (sIL7R), a fundamental driver of poor therapeutic response in autoimmune disease. https://mma.prnewswire.com/media/2564762/Autoimmunity_BioSolutions_Logo.jpg ABS announced key
Cheetah Mobile Inc. (“Cheetah Mobile” or the “Company”) (NYSE: CMCM), a China-based IT company, today announced that it will report its financial results for the third quarter 2025 before the U.S. market opens on Wednesday, November 26, 2025. The earnings release will be available on the Company's investor relations website at http://ir.cmcm.com. Cheetah Mobile's management
Fujitsu today announced its recognition as an Emerging Leader in the Gartner Emerging Market Quadrant for Generative AI Engineering in the Innovation Guide for Generative AI Engineering, published on November 13, 2025. Since March 2025, Fujitsu has remained the only Japan-headquartered company to be recognized as an Emerging Leader in this report. Fujitsu has been
Avicanna Announces Pre-Clinical Data Supporting Enhanced Absorption and Patent Filing for Novel Oral Delivery Platform GlobeNewswire November 19, 2025 PwdRx novel drug delivery platform demonstrated superior bioavailability and accelerated absorption of cannabinoids in preclinical studies Provisional patent application on the novel drug delivery platform which can be loaded into products such as tablets, capsules, sachets
FG Nexus CEO of Digital Assets Maja Vujinovic to Participate in the 2025 Clear Street Disruptive Technology Conference GlobeNewswire November 19, 2025 Charlotte, NC, Nov. 19, 2025 (GLOBE NEWSWIRE) — FG Nexus (Nasdaq: FGNX, FGNXP) (the “Company” or “FG Nexus”), today announced that CEO of Digital Assets Maja Vujinovic will participate in the panel “Tokenizing
H2O America Announces Deferral of San Jose Water Company's Cost of Capital Filing to May 1, 2027 GlobeNewswire November 19, 2025 Upholds San Jose Water's current 9.81% allowed return on equity (ROE), which is the CPUC-approved 10.01% base ROE prior to a 20-basis-point reduction related to the Water Conservation Memorandum Account (WCMA) Timing for next